Clinical impact of adherence to guidelines on the outcome of chronic heart failure in Japan

International Heart Journal

Volumn 49, Issue 1, 2008, Pages 59-73

  Ohsaka, Tsutomu ^a   Inomata, Takayuki ^a   Naruke, Takashi ^a   Shinagawa, Hisahito ^a   Koitabashi, Toshimi ^a   Nishii, Mototsugu ^a   Takeuchi, Ichiro ^a   Takehana, Hitoshi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adherence; Angiotensin converting enzyme; Beta blocker; Chronic heart failure; Clinical outcome; Guideline

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; CHRONIC DISEASE; FOLLOW UP; HEART STROKE VOLUME; MIDDLE AGED;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HEART FAILURE; HUMANS; JAPAN; MALE; MIDDLE AGED; STROKE VOLUME; TREATMENT OUTCOME;

EID: 43249100100     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.59     Document Type: Article

References (26)

1. Houghton AR, Cowley AJ. Why are angiotensin converting enzyme inhibitors underutilised in the treament of heart failure by general practitioners? Int J Cardiol 1997; 59: 7-10.
2. Philbin EF, Andreaou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996; 77: 832-8.
3. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-235.
4. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the Europew Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
5. Heart Failure Society Of America. MA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006; 12: e1-2.
6. Matsuzaki M, Aizawa, Y, Assnoi E, et al. Guidelines for Treatment of Chronic Heart Failure (JCS 2005). Available at http://www.j-circ.or.jp/guideline/JCS2005_matsuzaki_h.pdf. (Japanese)
7. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65. (Review)
8. Matsuzaki M, Sasayama S, Aizawa Y, et al. Guidelines for Treatment of Chronic Heart Failure. Jpn Circ J 2001; 65 (Suppl IV): 941-61 (Japanese)
9. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J 2007; 71: 449-54.
10. Shiba N, Watanabe J, Shinozaki T, et al. Analysis of chronic heari failure registry in the Tohoku district: third year follow-up. Circ J 2004; 68: 427-34.
11. Komajda M, Follath F, Swedberg K, et al. The Euro Heart Failure Survey programme - a survey on the quality of care among patients with heart fidlure in Europe. Part 2: treatment. Eur Heart J 2003; 24: 464-74.
12. Smith NL, Chan JD, Rea TD, et al. Time trends in the use of β-blockers and other pharmacotherapies in older adults with congestive heart failure. Am Heart J 2004; 148: 710-7.
13. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001; 88: 530-3.
14. National Committee for Quality Assurance. The state of health care quality, 2007. Available at http://web.ncqa.org/Portals/0/Publications/ Resource%20Library/SOHC/SOHC_07.pdf.
15. Cardiology Preeminence Roundtable. Beyond four walls: research summary for clinicians and administrators on CHF management. Advisory Board. Washington, DC, 1994.
16. Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005; 26: 1653-9.
17. Wikstrand J, Hjalmarson A, Waagstein F, et al. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol 2002; 40: 491-8.
18. Miller AB, Christopher O, Coats AJ, et al. Dose digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS study. JACC 2002; 39 (Suppl 1): 116.
19. Ghali JK, Dunselman P, Waagstein F, et al. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis. J Card Fail 2004; 10: 452-9.
20. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med 2003; 18: 967-76.
21. McMurray J, Cohen-Solal A, Dietz R, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 2005; 7: 710-21.
22. Ansari M, Shlipak MG, Heidenreich PA, et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation 2003; 107: 2799-804.
23. Ellrodt G, Glasener R, Cadorette B, et al. Multidisciplinary rounds (MDR): an implementation system for sustained improvement in the American Heart Association's Get With The Guidelines program. Crit Pathw Cardiol 2007; 6: 106-16.
24. Matthews JC, Johnson ML, Koelling TM. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure. Am Heart J 2007; 154: 1174-83.
25. American Hew Association. Get With The Guidelines-Heart Failure. Available at. http:///americanheart.org/downloadable/heart/ 1163802072170HFFactSheet.pdf.
26. Costantini O, Huck K, Carlson MD, et al. Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive head failure. Arch Intern Med 2001; 161: 177-82.